ROLLOVER GUIDE
This guide will transition you from the 5th Edition to the 6th Edition of Pharmacotherapeutics for Advanced Practice Nurse Prescribers.
Publication Date: 4/16/2024
ABOUT THE 6TH EDITION …
The Pharmacotherapeutics for Advanced Practice Nurse Prescribers text, online case studies, and Davis Edge online quizzing work together to create an interactive learning solution that helps students master advanced pharmacology content and prepares them for their roles as Advanced Practice Nurse Prescribers. An access code inside new, printed texts unlocks Davis Edge, as well as the online case studies and ebook. Or, go all-digital with the purchase of the ebook version of the text that also includes access to Davis Edge and the online case studies. NEW TO THIS EDITION ▪ Expanded, Revised & Updated! Thoroughly updated to reflect current scientific knowledge, clinical practice, the newest evidence and changes in health care. ▪ New Chapters! Cannabis, Obesity, and Covid-19: Acute and Chronic ▪ New Content! Coverage of opioids and biologics, including DMARDs ▪ New! Drugs for migraines and asthma, as well as MABS and their use in primary and urgent care ▪ Expanded! Content on pharmacogenetics and genomics ▪ New co-author! Wendy Wright
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Teri Moser Woo RN, PhD, ARNP, CPNP-PC, CNL, FAANP Wendy L. Wright DNP, ANP-BC, FNP-BC, FAAN, FNAP
ISBN-13: 978-1-7196-4803-5 © 2024 Hardback 1424 pages
STUDENT RESOURCES ▪ eBook ▪ Davis Edge ▪ Student Learning Activities with Critical-Thinking Questions ▪ Animations
INSTRUCTOR RESOURCES ▪ eBook
▪ Davis Edge ▪ Test Bank ▪ Instructor-Only Online Case Studies with Suggested Answers ▪ PowerPoint Presentations ▪ Answers to Student Learning Activities
FADavis.com 1
This Rollover Guide will help you easily transition to the 6th Edition of Pharmacotherapeutics for Advanced Practice Nurse Prescribers. Note that content from the 5th Edition may now be found in a different chapter in the 6th Edition.
Woo: Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Woo: Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
UNIT I. THE FOUNDATION
The Role of the Nurse Practitioner as Prescriber
Chapter 1, page 3
Chapter 1, page 1
Review of the Basic Principles of Pharmacology
Chapter 2, page 17
Chapter 2, page 12
Rational Drug Selection
Chapter 3, page 35
Chapter 3, page 29
Legal and Professional Issues in Prescribing
Chapter 4, page 43
Chapter 4, page 36
Adverse Drug Reactions
Chapter 5, page 57
Chapter 5, page 48
An Introduction to Pharmacogenetics
Chapter 6, page 67
Chapter 6, page 58
Nutrition and Neutraceuticals
Chapter 7, page 79
Chapter 7, page 70
Herbal Therapies
Chapter 8, page 95
Chapter 8, page 85
FADavis.com 2
Cannabis
Chapter 8, page 113
Chapter 9, page 107
Pharmacoeconomics
Chapter 10, page 131
Chapter 10, page 113
UNIT II. PHARMACOTHERAPEUTICS WITH SINGLE DRUGS
Drugs Affecting the Autonomic Nervous System
Chapter 11, page 139
Chapter 11, page 119
Drugs Affecting the Central Nervous System
Chapter 12, page 193
Chapter 12, page 161
Drugs Affecting the Cardiovascular and Renal Systems
Chapter 13, page 271
Chapter 13, page 238
Drugs Affecting the Respiratory System
Chapter 14, page 337
Chapter 14, page 300
Drugs Affecting the Hematological System
Chapter 15, page 391
Chapter 15, page 350
Drugs Affecting the Immune System: Vaccines and Immunoglobulins
Chapter 16, page 425
Chapter 16, page 382
Drugs Affecting the Immune System: Immunomodulators
Chapter 16, page 473
Chapter 17, page 448
Drugs Affecting the Gastrointestinal System
Chapter 17, page 479
Chapter 18, page 460
Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs
Chapter 18, page 523
Chapter 19, page 505
Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs
Chapter 19, page 571
Chapter 20, page 551
Drugs Affecting the Reproductive System
Chapter 20, page 595
Chapter 21, page 575
FADavis.com 3
Drugs Affecting the Bones and Joints
Chapter 21, page 631
Chapter 22, page 609
Drugs Affecting the Integumentary System
Chapter 22, page 667
Chapter 23, page 645
Drugs Used to Treat Bacterial Infections
Chapter 23, page 713
Chapter 24, page 689
Drugs Used to Treat Viral, Fungal, and Protozoal Infections
Chapter 24, page 781
Chapter 25, page 748
Drugs Used to Treat Inflammatory Processes
Chapter 25, page 813
Chapter 26, page 781
Drugs Used to Treat Eye and Ear Disorders
Chapter 26, page 839
Chapter 27, page 807
UNIT III. PHARMACOTHERAPEUTICS WITH MULTIPLE DRUGS
Anemia
Chapter 28, page 877
Chapter 28, page 831
Anxiety and Depression
Chapter 30, page 907
Chapter 29, page 846
Attention Deficit Hyperactivity Disorder
Chapter 31, page 925
Chapter 30, page 863
Asthma and Allergy
Chapter 32, page 937
Chapter 31, page 876
Chronic Obstructive Pulmonary Disease
Chapter 32, page 960
Chapter 32, page 897
Contraception
Chapter 33, page 967
Chapter 33, page 904
Covid-19: Acute and Chronic
N/A
Chapter 34, page 919
FADavis.com 4
Dermatological Conditions
Chapter 34, page 983
Chapter 35, page 932
Diabetes Mellitus
Chapter 35, page 1017
Chapter 36, page 961
Gastroesophageal Reflux and Peptic Ulcer Disease
Chapter 36, page 1053
Chapter 37, page 997
Headaches
Chapter 37, page 1069
Chapter 38, page 1012
Heart Failure
Chapter 38, page 1101
Chapter 39, page 1045
Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome
Chapter 39, page 1119
Chapter 40, page 1061
Menopausal Hormone Therapy
Chapter 40, page 1151
Chapter 41, page 1091
Hyperlipidemia
Chapter 41, page 1167
Chapter 42, page 1106
Hypertension
Chapter 42, page 1195
Chapter 43, page 1133
Hyperthyroidism and Hypothyroidism
Chapter 43, page 1221
Chapter 44, page 1156
Obesity
N/A
Chapter 45, page 1172
Pain Management: Acute and Chronic Pain
Chapter 44, page 1239
Chapter 46, page 1182
Pneumonia
Chapter 45, page 1259
Chapter 47, page 1203
Sexually Transmitted Infections
Chapter 47, page 1281
Chapter 48, page 1214
FADavis.com 5
Substance Use Disorders
Chapter 27, page 867
Chapter 49, page 1230
Tuberculosis
Chapter 48, page 1303
Chapter 50, page 1248
Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa
Chapter 49, page 1319
Chapter 51, page 1263
Urinary Tract Infection
Chapter 50, page 1333
Chapter 52, page 1276
UNIT IV. SPECIAL DRUG TREATMENT CONSIDERATIONS
Women as Patients
Chapter 51, page 1349
Chapter 53, page 1289
Men as Patients
Chapter 52, page 1369
Chapter 54, page 1307
Pediatric Patients
Chapter 53, page 1387
Chapter 55, page 1322
Transgendered Persons as Patients
Chapter 54, page 1403
Chapter 56, page 1337
Geriatric Patients
Chapter 55, page 1413
Chapter 57, page 1349
FADavis.com 6
RECOMMENDED RESOURCES
NP Notes: Nurse Practitioner's Clinical Pocket Guide 4th Edition
Ruth McCaffrey DNP, ARNP, FNP-BC, GNP-BC, FAANP Humberto Reinoso PhD, FNP-BC, ENP-BC
ISBN-13: 978-1-7196-4448-8 © 2021 Spiral Bound 298 pages
Creative Teaching Strategies for the Nurse Educator 3rd Edition
Judith W. Herrman RN, PhD, ANEF, FAAN
ISBN-13: 978-0-8036-9405-7 © 2020 Paperback 456 pages
FADavis.com 7
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7Powered by FlippingBook